Is it your opinion only that 'PAA do not need to advise them (FDA)'?
Otherwise please provide documentary evidence that the FDA do not require notification of material information for them to include in their consideration of ODD.
Ann: Appendix 4C & Quarterly Update, page-66
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |